{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:17:45Z","timestamp":1790630265600,"version":"4.1.0"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,2]]},"DOI":"10.18632\/oncotarget.16628","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T18:02:40Z","timestamp":1490724160000},"page":"30383-30394","source":"Crossref","is-referenced-by-count":12,"title":["Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments"],"prefix":"10.18632","volume":"8","author":[{"given":"Oliver C.","family":"Goodyear","sequence":"first","affiliation":[{"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Essex","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandram","family":"Seetharam","sequence":"additional","affiliation":[{"name":"Department of Haematology, The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supratik","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Haematology, The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moss","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"},{"name":"Birmingham Health Partners, Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"},{"name":"Birmingham Health Partners, Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Rajkumar","year":"2009","journal-title":"Blood"},{"key":"2","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Kuehl","year":"2009","journal-title":"Blood"},{"key":"3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and immunotherapy in multiple myeloma","volume":"138","author":"Moss","year":"2007","journal-title":"Br J Haematol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/cncr.21746","article-title":"Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic\/Th1 T cells demonstrating a squed TCR-Vbeta repertoire","volume":"106","author":"Orfao","year":"2006","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/sj.leu.2400714","article-title":"The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma","volume":"11","author":"Joshua","year":"1997","journal-title":"Leukemia"},{"key":"6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hon.704","article-title":"T cells in myeloma","volume":"21","author":"Joshua","year":"2003","journal-title":"Hematol Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-04-3337","article-title":"Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors","volume":"65","author":"Borrello","year":"2005","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","article-title":"peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma","volume":"107","author":"Schultze","year":"2006","journal-title":"Blood"},{"key":"9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1365-2141.2008.07530.x","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(\u2212)CD8(\u2212)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden","volume":"144","author":"Cook","year":"2009","journal-title":"Br J Haematol"},{"key":"10","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1182\/blood-2009-10-246660","article-title":"Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma","volume":"115","author":"Daley","year":"2010","journal-title":"Blood"},{"key":"11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.leukres.2010.11.010","article-title":"Significantly reduced regulatory T cell population in patients with untreated multiple myeloma","volume":"35","author":"Kumar","year":"2011","journal-title":"Leuk Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3324\/haematol.2014.105866","article-title":"The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status","volume":"99","author":"Massaia","year":"2014","journal-title":"Haematologica"},{"key":"13","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1182\/blood-2010-05-283895","article-title":"A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma","volume":"116","author":"Borrello","year":"2010","journal-title":"Blood"},{"key":"14","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice","volume":"59","author":"Wijdenes","year":"1999","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000055357","article-title":"Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice","volume":"61","author":"Tamura","year":"2001","journal-title":"Oncology"},{"key":"16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood.V99.6.2114","article-title":"Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism","volume":"99","author":"Tartour","year":"2002","journal-title":"Blood"},{"key":"17","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"Lotze","year":"2003","journal-title":"Blood"},{"key":"18","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.4049\/jimmunol.175.9.6177","article-title":"IL-17 enhances the net angiogenic activity andgrowth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis","volume":"175","author":"Sasaki","year":"2005","journal-title":"J Immunol"},{"key":"19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"key":"20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood-2008-09-177360","article-title":"Endogenous IL-17 contributes to reduced tumor growth and metastasis","volume":"114","author":"Zou","year":"2009","journal-title":"Blood"},{"key":"21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Liu","year":"2009","journal-title":"Blood"},{"key":"22","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","article-title":"Protumor vs antitumor functions of IL-17","volume":"183","author":"Saha","year":"2009","journal-title":"J Immunol"},{"key":"23","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"184","author":"Peng","year":"2010","journal-title":"J Immunol"},{"key":"24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ejim.2006.02.012","article-title":"Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma","volume":"17","author":"Stathopoulos","year":"2006","journal-title":"Eur J Intern Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-03-143222","article-title":"Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma","volume":"112","author":"Dhodapkar","year":"2008","journal-title":"Blood"},{"key":"26","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Takayanagi","year":"2006","journal-title":"J Exp Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1182\/blood-2014-02-558742","article-title":"CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma","volume":"124","author":"Ghobria","year":"2014","journal-title":"Blood"},{"key":"28","doi-asserted-by":"publisher","first-page":"11283","DOI":"10.18632\/oncotarget.2207","article-title":"Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4\/CXCL12 axis and promote their polarization toward the M2 phenotype","volume":"5","author":"Nagler","year":"2014","journal-title":"Oncotarget"},{"key":"29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/leu.2015.259","article-title":"Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: role of chemokine (C-C motif) ligand 20","volume":"30","author":"Aversa","year":"2016","journal-title":"Leukemia"},{"key":"30","doi-asserted-by":"publisher","first-page":"24218","DOI":"10.18632\/oncotarget.4523","article-title":"Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma","volume":"6","author":"Cai","year":"2015","journal-title":"Oncotarget"},{"key":"31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cyto.2014.05.017","article-title":"Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease","volume":"69","author":"Yancey","year":"2014","journal-title":"Cytokine"},{"key":"32","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-15-1320","article-title":"Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment","volume":"75","author":"Bernardini","year":"2015","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Napolitani","year":"2007","journal-title":"Nat Immunol"},{"key":"34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2141.2005.05443.x","article-title":"Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells","volume":"129","author":"Vacca","year":"2005","journal-title":"Br J Haematol"},{"key":"35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.exphem.2010.06.012","article-title":"The cytokine\/chemokine pattern in the bone marrow environment of multiple myeloma patients","volume":"38","author":"Atanackovic","year":"2010","journal-title":"Exp Hematol"},{"key":"36","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.exphem.2006.06.017","article-title":"Chemokines in multiple myeloma","volume":"34","author":"Roodman","year":"2006","journal-title":"Exp Hematol"},{"key":"37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4049\/jimmunol.180.1.122","article-title":"Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells","volume":"180","author":"Kim","year":"2008","journal-title":"J Immunol"},{"key":"38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nri2654","article-title":"The functional plasticity of T cell subsets","volume":"9","author":"Stockinger","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10585-007-9108-4","article-title":"Extravasation and homing mechanisms in multiple myeloma","volume":"25","author":"Van Riet","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/sj.leu.2403833","article-title":"Multiple myeloma oncogene 1 (MUM1)\/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy","volume":"19","author":"Ueda","year":"2005","journal-title":"Leukemia"},{"key":"41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3324\/haematol.2009.015628","article-title":"Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells","volume":"95","author":"Zannettino","year":"2010","journal-title":"Haematologica"},{"key":"42","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3109\/10428194.2016.1151511","article-title":"Monokine induced by interferon gamma (MIG\/CXCL9) is an independent prognostic factor in newly diagnosed myeloma","volume":"57","author":"Ludwig","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2141.2003.04040.x","article-title":"Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM","volume":"120","author":"Mitsuya","year":"2003","journal-title":"Br J Haematol"},{"key":"44","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1182\/blood-2010-04-279760","article-title":"Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration","volume":"117","author":"Klein","year":"2011","journal-title":"Blood"},{"key":"45","doi-asserted-by":"publisher","first-page":"24218","DOI":"10.18632\/oncotarget.4523","article-title":"Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma","volume":"6","author":"Cai","year":"2015","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Paul","year":"2008","journal-title":"Blood"},{"key":"47","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-15-1320","article-title":"Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment","volume":"75","author":"Bernardini","year":"2015","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/leu.2014.121","article-title":"Heparanase enhances myeloma progression via CXCL10 downregulation","volume":"28","author":"Vlodavsky","year":"2014","journal-title":"Leukemia"},{"key":"49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/leu.2015.259","article-title":"Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: role of chemokine (C-C motif) ligand 20","volume":"30","author":"Aversa","year":"2016","journal-title":"Leukemia"},{"key":"50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bjh.13519","article-title":"JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells","volume":"171","author":"Mufti","year":"2015","journal-title":"Br J Haematol"},{"key":"51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coph.2016.02.013","article-title":"New approaches to targeting the bone marrow microenvironment in multiple myeloma","volume":"28","author":"Edwards","year":"2016","journal-title":"Curr Opin Pharmacol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:49:26Z","timestamp":1589136566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":51,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,5,2]]}},"alternative-id":["16628","28389623"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16628","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}